SK Biopharmaceuticals Co., Ltd.

Informe acción KOSE:A326030

Capitalización de mercado: ₩7.8t

SK Biopharmaceuticals Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Dong Hoon Lee

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO2.8yrs
Participación del CEO0.004%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva3.2yrs

Actualizaciones recientes de la dirección

Recent updates

SK Biopharmaceuticals Co., Ltd. (KRX:326030) Shares Could Be 47% Below Their Intrinsic Value Estimate

Nov 27
SK Biopharmaceuticals Co., Ltd. (KRX:326030) Shares Could Be 47% Below Their Intrinsic Value Estimate

There May Be Underlying Issues With The Quality Of SK Biopharmaceuticals' (KRX:326030) Earnings

Aug 22
There May Be Underlying Issues With The Quality Of SK Biopharmaceuticals' (KRX:326030) Earnings

SK Biopharmaceuticals Co., Ltd. (KRX:326030) Looks Just Right With A 25% Price Jump

Aug 21
SK Biopharmaceuticals Co., Ltd. (KRX:326030) Looks Just Right With A 25% Price Jump

Does This Valuation Of SK Biopharmaceuticals Co., Ltd. (KRX:326030) Imply Investors Are Overpaying?

May 22
Does This Valuation Of SK Biopharmaceuticals Co., Ltd. (KRX:326030) Imply Investors Are Overpaying?

SK Biopharmaceuticals Co., Ltd. (KRX:326030) Not Lagging Industry On Growth Or Pricing

Apr 09
SK Biopharmaceuticals Co., Ltd. (KRX:326030) Not Lagging Industry On Growth Or Pricing

Is SK Biopharmaceuticals (KRX:326030) A Risky Investment?

Feb 27
Is SK Biopharmaceuticals (KRX:326030) A Risky Investment?

We're Not Worried About SK Biopharmaceuticals' (KRX:326030) Cash Burn

Mar 12
We're Not Worried About SK Biopharmaceuticals' (KRX:326030) Cash Burn

CEO

Dong Hoon Lee (56 yo)

2.8yrs

Permanencia

Mr. Dong Hoon Lee serves as Chief Executive Officer of SK Biopharmaceuticals Co., Ltd. since 2022 and also served as its Chairman of the Board since February 26, 2020. He is President of SK Biopharmaceutic...


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Dong Hoon Lee
CEO, President & Executive Director4.8yrssin datos0.0038%
₩ 299.6m
Jiyoung Jung
CFO & Executive Directorless than a yearsin datossin datos
William Koster
Member of Advisory Boardno datasin datossin datos
Gary Bennett
Member of Advisory Boardno datasin datossin datos
Emilio Perucca
Member of Advisory Boardno datasin datossin datos
Frank Castellana
Member of Advisory Boardno datasin datossin datos
Linda Watkins
Member of Advisory Boardno datasin datossin datos
H. White
Member of Advisory Boardno datasin datossin datos
Min-Ji Kim
Independent Director1.7yrssin datossin datos
Min Sop Song
Independent Chairman of the Board5.3yrssin datossin datos
Yung Jue Bang
Chairman of the Scientific Advisory Board1.3yrssin datossin datos
Hae Young Ahn
Independent Outside Director5.3yrssin datossin datos

3.2yrs

Permanencia media

Junta con experiencia: La junta directiva de A326030 se considera experimentada (3.2 años de antigüedad promedio).